Skip to main content
FDA Demands Allergan Inc. Breast Implant Recall

Author: Wallace & Graham, P.A.

Published: Monday, January 11, 2021

FDA Demands Allergan Inc. Breast Implant Recall


Breast implant manufacturer, Allergan, Inc. has recalled certain textured breast implants and tissue expanders at the request of the Federal Food and Drug Administration following a significant increase in reported cases of breast implant-associated Anaplastic Large Cell Lymphoma, (BIA-ALCL), a type of non-Hodgkin’s Lymphoma. 

 The FDA has received a total of 573 reports of breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) from both US and global medical device reports.  The FDA is not recommending women with the implants have them removed because the cancer is so rare, but say they should check with their doctor if they have symptoms, which include pain and swelling.

 A complete list of recalled Allergan’s BIOCELL® implants can be found at https://www.fda.gov/medical-devices/safety-communications/fda-requests-allergan-voluntarily-recall-natrelle-biocell-textured-breast-implants-and-tissue#list

 It is important that you discuss any medical concerns with your doctor.  However, should you wish to discuss this matter with our office, call 1-800-849-5291 for a free consultation.